T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor

LEXINGTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of a territory exclusive distribution agreement in Hong Kong and Macau. Under the terms of the agreement, T2 Biosystems will sell the T2Dx^® Instrument, the T2Bacteria^® Panel, the T2Candida^® Panel, and the T2Resistance^® Panel through the newly appointed distributor.

Read more at globenewswire.com